Maternal diabetes induces gene suppression, oxidative stress, and inflammation in PBMCs and IECs, subsequently contributing to GI dysfunction in autism‐like animal models, while HSCT with increased Sod2 expression partly reverses this effect and subsequently ameliorates maternal diabetes–mediated ALB. The gene discussed is SOD2; the disease is autism.